Development of contrast media for magnetic resonance imaging.
Goldstein
H A
HA
Wiggins
J R
JR
Kashanian
F
F
D000818:Animals; D001921:Brain / Q000473:pathology; D003287:Contrast Media; D004338:Drug Combinations; D005682:Gadolinium; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000009:adverse effects; D008536:Meglumine / Q000009:adverse effects / Q000633:toxicity; D009942:Organometallic Compounds / Q000009:adverse effects / Q000633:toxicity; D004369:Pentetic Acid / Q000009:adverse effects / Q000633:toxicity; D012449:Safety; D013116:Spinal Cord / Q000473:pathology
D003287:Contrast Media; D004338:Drug Combinations; D009942:Organometallic Compounds; D008536:Meglumine; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA